AIPT Precision Therapeutics Inc.

Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announced today that Dr. Carl Schwartz, Interim Chief Executive Officer of Skyline Medical; Bob Beringer, Chief Executive Officer of Electronic On-Ramp; and Richard Gabriel, Co-founder and Chief Operating Officer of GLG Pharma, LLC. will be interviewed on WPSL’s “MONEYINFO by PRINCETON RESEARCH with MIKE KING and CHARLES MOSKOWITZ” show on Tuesday, September 27th.  The show will begin at 10:05 a.m. Eastern time and management’s interview will begin at 10:20 a.m.

Management is expected to discuss recent news that Skyline Medical has signed a partnership agreement with GLG, which intends to develop rapid diagnostic tests that utilize fluid and tissue collected by the STREAMWAY System during procedures, and its expected joint venture with Electronic On-Ramp to supply STREAMWAY to U.S. government mobile operating rooms, including disaster relief sites.

To listen to the interview live, investors may visit WPSL’s website at www.wpsl.com.  A replay will be available on the investor relations section of Skyline Medical’s website at www.skylinemedical.com.

About Skyline Medical Inc.Skyline Medical Inc. produces a fully automated, patented, FDA-cleared, waste fluid disposal system that virtually eliminates staff exposure to blood, irrigation fluid and other potentially infectious fluids found in the healthcare environment. Antiquated manual fluid handling methods — which require hand carrying and emptying filled fluid canisters — present an exposure risk and potential liability. Skyline Medical's STREAMWAY System fully automates the collection, measurement and disposal of waste fluids and is designed to: 1) reduce overhead costs to hospitals and surgical centers, 2) improve compliance with OSHA and other regulatory agency safety guidelines, 3) improve efficiency in the operating room, and radiology and endoscopy departments — leading to greater profitability, and 4) provide greater environmental stewardship by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United States. For additional information, please visit www.skylinemedical.com.

Contact:
Investors
LHA
Kim Sutton Golodetz
(212) 838-3777
kgolodetz@lhai.com
   or
Bruce Voss
bvoss@lhai.com
310-691-7100